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INTRODUCTION
Sickle cell anaemia (SCA) is the predominant
haemoglobinopathy in Nigeria affecting about 1-3%
of the Nigerian population 1. The disease is associated
with a lot of physical, psychosocial, emotional and
financial burden and could lead to a disruption of
family life 2. Studies from Nigeria have shown different
levels of perception of the disease among family
members3 and caregivers4 and among enlightened
members of the public5.  The disease runs a chronic
course but is now curable using gene therapy and bone
marrow transplantation 6. However, these novel means
of therapy are not yet widely available in developing
countries like Nigeria hence the importance of
preventive measures in these settings. The availability
of prenatal diagnosis (PND) for the disease has
opened a window of opportunity for expectant
couples to have information about the haemoglobin
(Hb) genotype of their unborn child. This gives them
the option of  termination of  the pregnancy in case of
positive result and to prepare them psychologically,
financially and medically for the arrival of the new
child when abortion is not an option.  It is interesting
to note that many of the respondents in the studies
cited earlier are aware of this possibility even though
the test is not widely available in Nigeria (as at the time
of the study)3,4,5. Studies from Europe have shown
that using prenatal diagnosis PND has led to a
reduction in the incidence of some genetic disorders
like cystic fibrosis and haemoglobinopathies7, 8.  Prenatal
diagnosis is usually carried out using either chorionic
villus sampling (CVS) or amniocentesis and the samples
taken have DNA analysis done on them. Both
procedures are invasive with CVS being done between
the 10th and 12th week of pregnancy while
amniocentesis is usually carried out later (between the
14th and 20th week). Prenatal testing for genetic
conditions generally is associated with a lot of ethical
concerns and sickle cell anaemia is not an exception.
The aim of this work is to discuss some of these issues
especially in the context of a developing country like
Nigeria.
ETHICAL ISSUES
The issue of safety of the procedures used for PND
is worth mentioning first. Though they are found to
be relatively safe, there is still a chance of a miscarriage
following chorionic villus sampling and amniocentesis
(worse with CVS and usually multi-factorial)  9,10.
Abortion of the affected fetus is regarded as a
component of  PND in most cases. In the case of  the
fetus having the SS genotype, the ethical question arises
whether to have an abortion or to keep the pregnancy.
The decision whether to terminate a pregnancy based
on a positive result is usually a difficult one that involves
religious, psychosocial and cultural considerations1.
Another reason why the abortion of an affected fetus
may not be accepted is because of the risk of
complications mainly due to lack of reliable and safe
health care practices in developing countries. Even
when abortion is legal in the local context, the question
whether it is right to terminate an innocent life is still a
much debated issue. If on the other hand, a decision
is made to keep the pregnancy, the question whether it
is right or not to bring a child with a disease condition
that causes so much suffering to the world. Utilitarians
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would argue that it is more cost effective to abort the
affected fetuses as this will reduce on the long run the
socio-economic and emotional consequences of the
disease. Bringing up the question of cost-effectiveness
and life of patients would be looked at in many
developing countries like Nigeria as being cold and
inhuman, but the reality of scarcity of resources and
rationing of health care resources is there for all to
see. The introduction of pre-implantation genetic
diagnosis (PGD) in developed countries would seem
to have put the controversial issue of  termination of
affected pregnancy at rest as only “genetically healthy”
embryos will be transferred to the uterus. The practice
itself is laden with its’ own ethical dilemmas relating
to: the moral status and destruction of embryos,
tendencies for eugenic practices (selection of particular
traits in the embryo), the possibility of  long term
complications from the procedure and distributive
justice issues11. Opponents of these prenatal or pre-
implantation tests would also argue that SCA is now
becoming a chronically manageable disease with
increase in life expectancy and quality of life of patients
hence there is no reason for these investigations.
Some people would argue that using a prenatal
diagnosis for SCA would lead to a systematic
elimination of the genetic mutation from the
population. Could this be called a form of  eugenics?
The author definitely does not think so as the choice
here is not about specific traits that are desired in a
child but having a child free of a particular genetic
disorder. The right to know is a fundamental right of
the couple hence carrying out a PND for SCA actually
empowers the couple to plan for the new child (if
they decide to keep the pregnancy – if SS genotype)
and gives them peace of mind (if AS or AA genotype).
This is the autonomous choice of the couple, a right
to decide what is acceptable to them. There is also the
risk of pressure being put on the couple directly or
indirectly by the society to have prenatal diagnosis done
because of the availability of the tests (the so called
technological imperative). This could lead to affected
couples being blamed for not making use of the tests
to avoid having children with sickle cell disease.
The scope of genetic counseling offered by health care
workers (clinical geneticist, haematologist, nurse or
obstetrician) has a lot of  ethical implications. Several
studies have clearly shown that genetic counseling is
considered as one of the best ways of controlling the
disease12. As usual with genetic counseling a “non-
directive” and “client-centered” form of  counseling
is preferred. This form of  counseling entails disclosure
of  genetic risk information necessary for the clients to
make an informed decision without direct or indirect
advice from the counselors. But the question whether
it is possible to be absolutely non-directive in counseling
is one that is generating a lot of debates among
bioethicists and geneticists 13. How can one ignore his
or her own intuition and sense of morality when
confronted with challenging situations? Is it possible
for a counselor who is a practicing Roman Catholic
to be value- neutral when discussing abortion as an
option after PND? Counseling for SCA is even more
problematic because of the variability in severity of
the disease among different patients: while some live
fairly crises-free lives for long (50-60yrs), some die
during childhood or adolescence. So how do we know
which form of  the disease the unborn child is going
to develop?
Finally, the principle of  justice in health care requires
that access to PND be fair and equitable. This is
definitely not so because of intra-country and inter-
country disparity in access to PND;  many people
requiring prenatal diagnosis for SCA may not have
access to it because of  lack of  the service in their
environment or inability to pay for the services. This is
particularly common in developing countries of Sub-
Saharan Africa where payment for health care is still
mainly “out of pocket”14. This problem of access to
prenatal diagnosis remains one of the major
impediments to the control of SCD in developing
countries.
CONCLUSION
This review article has clearly shown the ethical
dimensions of prenatal diagnosis in the setting of a
developing country like Nigeria. It is important for
health care providers to be conscious of these issues
especially when providing service to clients.  There is
also a need to build capacity in the area of genetic
counseling as a means of controlling the spread of
sickle cell anaemia.
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